MedPath

Ness, Gregory M DDS

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

594

Active:46
Completed:332

Trial Phases

6 Phases

Early Phase 1:8
Phase 1:25
Phase 2:25
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (438 trials with phase data)• Click on a phase to view related trials

Not Applicable
338 (77.2%)
Phase 4
37 (8.4%)
Phase 1
25 (5.7%)
Phase 2
25 (5.7%)
Early Phase 1
8 (1.8%)
Phase 3
5 (1.1%)

Spine Oncology Registry

Not yet recruiting
Conditions
Spine Tumor
Spine Metastases
Spine Cancer
First Posted Date
2025-11-06
Last Posted Date
2025-11-06
Lead Sponsor
Ohio State University
Target Recruit Count
3000
Registration Number
NCT07225491
Locations
🇺🇸

University of Michigan, Ann Arbor, Michigan, United States

🇺🇸

Rutgers Robert wood Johnson Medical School, New Brunswick, New Jersey, United States

🇺🇸

The Ohio State University Wexner Medical Center, Columbus, Ohio, United States

Fostering Agricultural Relationships and Meaning - Thriving on Kinship

Not Applicable
Recruiting
Conditions
Loneliness
Social Isolation
Rural Health
First Posted Date
2025-10-21
Last Posted Date
2025-10-21
Lead Sponsor
Ohio State University
Target Recruit Count
65
Registration Number
NCT07218965
Locations
🇺🇸

The Ohio State University Department of Psychiatry and Behavioral Health, Columbus, Ohio, United States

Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses

Not Applicable
Recruiting
Conditions
Presbyopia Correction
Presbyopia
First Posted Date
2025-10-20
Last Posted Date
2025-10-20
Lead Sponsor
Ohio State University
Target Recruit Count
30
Registration Number
NCT07218731
Locations
🇺🇸

The Ohio State University College of Optometry, Columbus, Ohio, United States

Solving Stigma Through POV Simulation: Enhancing Pharmacist Empathy-based Practices With Sickle Cell Disease Patients

Not Applicable
Conditions
Stigma
First Posted Date
2025-10-16
Last Posted Date
2025-10-16
Lead Sponsor
Ohio State University
Target Recruit Count
200
Registration Number
NCT07217548
Locations
🇺🇸

Ohio State University College of Pharmacy, Columbus, Ohio, United States

Implementation of TBI-RECOVER in Substance Use Treatment

Not Applicable
Not yet recruiting
Conditions
Traumatic Brain Injury
Substance Use Disorder (SUD)
First Posted Date
2025-10-10
Last Posted Date
2025-10-10
Lead Sponsor
Ohio State University
Target Recruit Count
900
Registration Number
NCT07215221
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 119
  • Next

News

IIT Madras Develops AI Framework PURE to Accelerate Drug Discovery Using Reinforcement Learning

IIT Madras researchers collaborated with Ohio State University to develop PURE, an AI framework that uses reinforcement learning to generate drug-like molecules that are easier to synthesize in laboratories.

Neucore Bio Receives $350K NIH Grant to Develop Exosome-Based Gene Therapy for Charcot-Marie-Tooth Disease

Neucore Bio secured a $350,000 STTR Phase I grant from NIH's NCATS to develop an exosome-based RNA therapy targeting Charcot-Marie-Tooth Disease Type 1A.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.